adlitterio66339

Circa adlitterio66339

Questo autore non ha riempito alcun dettaglio.
Finora adlitterio66339 ha creato 792 post nel blog.

28 05, 2025

Maria Antonietta Castaldi et al., BRAF V600E mutation associated with papillary high-grade serous ovarian cystadenocarcinoma in a 22q11.2DS patient

adlitterio663392025-07-04T16:23:13+02:00

22 05, 2025

Diatech Pharmacogenetics parteciperà all’ European Society of Human Genetics Congress 2025
Diatech Pharmacogenetics parteciperà all’ European Society of Human Genetics Congress 2025

Eventi, Notizie

Diatech Pharmacogenetics parteciperà all’ European Society of Human Genetics Congress 2025

adlitterio663392025-05-22T12:12:47+02:00

20 05, 2025

Mariavittoria Vescovo et al., Storage Time and DNA Quality Determine BRCA1/2 Sequencing Success in Prostate Cancer: A Multicentre Analysis with Therapeutic Implications

adlitterio663392025-07-04T16:19:57+02:00

20 05, 2025

UGT1A1 & DPYD: Safer chemotherapy starts with genotyping

adlitterio663392025-06-23T16:27:31+02:00

13 05, 2025

Shooting Cancer Highlights – Focus periodico su approvazioni e disponibilità di nuove terapie oncologiche a bersaglio molecolare

adlitterio663392025-06-23T16:26:52+02:00

8 05, 2025

Advancing Precision Medicine: Preventing ADRs with Pharmacogenomic Panel Testing
Advancing Precision Medicine: Preventing ADRs with Pharmacogenomic Panel Testing

Notizie

Advancing Precision Medicine: Preventing ADRs with Pharmacogenomic Panel Testing

adlitterio663392025-05-08T09:31:50+02:00

7 05, 2025

Laura Antolino et al., TP53 Arg72Pro Polymorphism and Pancreatic Cancer Susceptibility: Assessing rs1042522 as a Risk Factor for Pancreatic Cancer

adlitterio663392025-07-04T16:17:47+02:00

6 05, 2025

Francesca Boscolo Nata et al., Impact of intraoperative NBI on complete resections and recurrence in oral and oropharyngeal cancer

adlitterio663392025-07-04T16:14:11+02:00

1 05, 2025

Esther Fernández-Galán et al., Integrating ctDNA testing for EGFR analysis in advanced non-small cell lung cancer: strategies for clinical laboratories

adlitterio663392025-07-04T16:10:47+02:00

23 04, 2025

Diatech Pharmacogenetics parteciperà al 32esimo Congresso SEAP-IAP 2025
Diatech Pharmacogenetics parteciperà al 32esimo Congresso SEAP-IAP 2025

Eventi, Notizie

Diatech Pharmacogenetics parteciperà al 32esimo Congresso SEAP-IAP 2025

adlitterio663392025-04-23T15:30:09+02:00

Precedente 234 Successivo